Seaway Plastics Engineering | AI Transformation Index

Seaway Plastics Engineering is a structurally durable physical manufacturer whose core economics — precision molded components for regulated medical OEMs —...

Seaway Plastics EngineeringManufacturing (Manufacturing - Miscellaneous)Intermediate Capital Group

Overview

Seaway Plastics Engineering is a contract manufacturer specializing in precision plastic injection molding, Liquid Silicone Rubber (LSR) molding, mold making, and assembly for regulated industries (primarily medical), generating revenue on a fee-for-service basis tied to tooling development and production runs.

Executive Summary

Seaway Plastics Engineering is a structurally durable physical manufacturer whose core economics — precision molded components for regulated medical OEMs — are essentially immune to AI substitution, with meaningful switching costs, regulatory moats, and capital barriers protecting its competitive position. However, AI's transformative potential for this business is commensurately low: with the overwhelming majority of value creation rooted in physical production, there is no large cognitive workforce to compress and no way to multiply throughput through AI augmentation. For a PE investor, Seaway represents a defensive, AI-resilient asset where the strategic priority is operational and commercial excellence — not AI transformation — and where AI investment should be scoped narrowly to engineering workflow and quality automation rather than positioned as a thesis driver.

Durability

How resilient is this business against AI disruption?

FactorValue

Market Substitutability

9

Profit Pool Migration

7

Barrier to Entry

8

Disintermediation Exposure

8

Switching Costs

7
Total78.0
×

Opportunity

How big a deal is AI for this business?

FactorValue

AI Applicability

3

Improvement Magnitude

3

Transformation Upside

2

Domain Intelligence Amplification

4
Total30.0

48.4

Ciridae AI Score

Durability Rationale

Seaway's durability rests on the irreducibly physical nature of its output: precision-molded plastic and silicone components for regulated medical applications cannot be delivered by software, and the regulatory, capital, and validation barriers to entry mean AI-native competitors have no path to displace incumbents. Customer switching costs are meaningfully high due to tooling specificity and re-qualification burdens in medical supply chains, and Seaway's direct ownership of production assets — rather than a coordination or intermediary role — means there is no layer to disintermediate. The primary durability risk is not AI but rather offshoring or consolidation among larger contract manufacturers with greater scale economies.

Opportunity Rationale

AI's transformative potential for Seaway is structurally limited by the physical nature of the production function — the value-creating work happens on the plant floor, not in cognitive labor pools that AI can compress. The addressable AI opportunity is real but narrow: engineering design assistance, vision-based quality inspection, and documentation automation can reduce cycle times and overhead, but none of these unlock step-change economics or remove the binding constraint of press capacity and cleanroom space. This is not a business where PE-sponsored AI transformation would produce dramatic returns; the opportunity is incremental process improvement rather than fundamental model change.

Key Risks

Large-scale AI-assisted generative design tools could shift more prototype development in-house at major medical OEMs, reducing the need for external contract manufacturers at the early design stage and compressing Seaway's prototyping revenue.

The AI opportunity assessment could be too conservative if vision-based quality inspection and AI-driven process control prove more transformative than anticipated — particularly in cleanroom environments where defect detection speed and yield improvement have outsized economics, these applications could deliver more than incremental benefit.

Company Overview

HeadquartersPort Richey, Florida, United States
Products / Services
Plastic Injection Molding, Liquid Silicone Rubber (LSR) Injection Molding, Prototype Injection Molding, Low to Mid Volume Production, Mold Making, Cleanroom Injection Molding and Assembly, Post Molding Operations including ultrasonic welding, EMI shielding, pad printing, laser marking, painting, and product assembly.

PE / Ownership History

EventDetails
Seaway Plastics Engineering acquires MME Group under ICG ownership
September 30, 2022
ICG acquires Seaway Plastics Engineering
June 23, 2022

Executives

NameBackground
Kevin Stevens
Chief Executive Officer
Kevin Stevens has extensive experience in packaging and plastics industry leadership, including roles at Graham Packaging, Bilcare Research AG, and Mold-Rite Plastics. He holds an MBA from the University of Notre Dame.
Dave Mercer
Chief Financial Officer
Dave Mercer has a background in financial management with previous roles at MME Group Inc., 3M, and other manufacturing firms. He studied Accounting and Business/Management at the University of Wisconsin-Parkside.
Jason P. Robinson
Chief Technical Officer
Jason P. Robinson has extensive tooling engineering experience, including roles at Kincaid Plastics Inc. and Chapman Tool & Manufacturing, Inc. He studied Mechanical Engineering at Oakland Community College.
Robert Kretzmer
VP Sales & Marketing
Robert Kretzmer is based in Dallas-Fort Worth and has experience in sales and marketing within the plastics industry.
Paul Bernard
Retired President and Owner
Paul Bernard has 22 years of experience at Seaway Plastics Engineering, based in Port Richey, Florida.
Henry Smith
Engineering Manager
Henry Smith has over 33 years at Seaway Plastics Engineering, based in Port Richey, Florida.